The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
Open accessAbstract
Individuals with potential exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not necessarily develop PCR or antibody positivity, suggesting that some individuals may clear subclinical infection before seroconversion. T cells can contribute to the rapid clearance of SARS-CoV-2 and other coronavirus infections 1–3 . Here we hypothesize that pre-existing memory T cell responses, with cross-protective potential against SARS-CoV-2 (refs. 4–11 ), would expand in vivo to support rapid viral control, aborting infection. We measured SARS-CoV-2-reactive T cells, including those against the early transcribed replication–transcription complex (RTC) 12,13 , in intensively monitored healthcare workers (HCWs) who tested repeatedly negative according to PCR, antibody binding and neutralization assays (seronegative HCWs (SN-HCWs)). SN-HCWs had stronger, more multispecific memory T cells compared with a cohort of unexposed individuals from before the pandemic (prepandemic cohort), and these cells were more frequently directed against the RTC than the structural-protein-dominated responses observed after detectable infection (matched concurrent cohort). SN-HCWs with the strongest RTC-specific T cells had an increase in IFI27 , a robust early innate signature of SARS-CoV-2 (ref. 14 ), suggesting abortive infection. RNA polymerase within RTC was the largest region of high sequence conservation across human seasonal coronaviruses (HCoV) and SARS-CoV-2 clades. RNA polymerase was preferentially targeted (among the regions tested) by T cells from prepandemic cohorts and SN-HCWs. RTC-epitope-specific T cells that cross-recognized HCoV variants were identified in SN-HCWs. Enriched pre-existing RNA-polymerase-specific T cells expanded in vivo to preferentially accumulate in the memory response after putative abortive compared to overt SARS-CoV-2 infection. Our data highlight RTC-specific T cells as targets for vaccines against endemic and emerging Coronaviridae .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Gene Diversity in Subdivided Populations
Nei, M. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.12.3321 · Cited by 8,885
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Data, disease and diplomacy: GISAID's innovative contribution to global health
Elbe, S., & Buckland‐Merrett, G. (2017) · Global Challenges · doi:10.1002/gch2.1018 · Cited by 1,928
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Self-citationRydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Coronaviruses post-SARS: update on replication and pathogenesis
Perlman, S., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,764
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310
Cited by
The T cell immune response against SARS-CoV-2
Moss, P. (2022) · Nature Immunology · doi:10.1038/s41590-021-01122-w · Cited by 1,235
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
Hall, V., Foulkes, S., Insalata, F., Kirwan, P., Saei, A., Atti, A., Wellington, E., Khawam, J., Munro, K., Cole, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2118691 · Cited by 711
Self-citationCOVID-19 vaccine development: milestones, lessons and prospects
Li, M., Wang, H., Tian, L., Pang, Z., Yang, Q., Huang, T., Fan, J., Song, L., Tong, Y., & Fan, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00996-y · Cited by 434
Kundu, R., Narean, J. S., Wang, L., Fenn, J., Pillay, T., Fernandez, N. D., Conibear, E., Koycheva, A., Davies, M., Tolosa-Wright, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27674-x · Cited by 322
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
Goldblatt, D., Alter, G., Crotty, S., & Plotkin, S. A. (2022) · Immunological Reviews · doi:10.1111/imr.13091 · Cited by 298
Self-citation
Metadata
- Authors
- Swadling, L., Diniz, M. O., Schmidt, N. M., Amin, O. E., Chandran, A., Shaw, E., Pade, C., Gibbons, J. M., Le Bert, N., Tan, A. T., Jeffery-Smith, A., Tan, C. C. S., Tham, C. Y. L., Kucykowicz, S., Aidoo-Micah, G., Rosenheim, J., Davies, J., Johnson, M., Jensen, M. P., Joy, G., McCoy, L. E., Valdes, A. M., Chain, B. M., Goldblatt, D., Altmann, D. M., Boyton, R. J., Manisty, C., Treibel, T. A., Moon, J. C., COVIDsortium Investigators, Abbass, H., Abiodun, A., Alfarih, M., Alldis, Z., Andiapen, M., Artico, J., Augusto, J. B., Baca, G. L., Bailey, S. N. L., Bhuva, A. N., Boulter, A., Bowles, R., Boyton, R. J., Bracken, O. V., O’Brien, B., Brooks, T., Bullock, N., Butler, D. K., Captur, G., Champion, N., Chan, C., Collier, D., de Sousa, J. C., Couto-Parada, X., Cutino-Mogue, T., Davies, R. H., Douglas, B., Di Genova, C., Dieobi-Anene, K., Ellis, A., Feehan, K., Finlay, M., Fontana, M., Forooghi, N., Gaier, C., Gilroy, D., Hamblin, M., Harker, G., Hewson, J., Hickling, L. M., Hingorani, A. D., Howes, L., Hughes, A., Hughes, G., Hughes, R., Itua, I., Jardim, V., Lee, W.-Y. J., Jensen, M. P., Jones, J., Jones, M., Joy, G., Kapil, V., Kurdi, H., Lambourne, J., Lin, K.-M., Louth, S., Mandadapu, V., McKnight, Á., Menacho, K., Mfuko, C., Mitchelmore, O., Moon, C., Munoz-Sandoval, D., Murray, S. M., Noursadeghi, M., Otter, A., Palma, S., Parker, R., Patel, K., Pawarova, B., Petersen, S. E., Piniera, B., Pieper, F. P., Pope, D., Prossora, M., Rannigan, L., Rapala, A., Reynolds, C. J., Richards, A., Robathan, M., Sambile, G., Semper, A., Seraphim, A., Simion, M., Smit, A., Sugimoto, M., Taylor, S., Temperton, N., Thomas, S., Thornton, G. D., Tucker, A., Veerapen, J., Vijayakumar, M., Welch, S., Wodehouse, T., Wynne, L., Zahedi, D., van Dorp, L., Balloux, F., McKnight, Á., Noursadeghi, M., Bertoletti, A., & Maini, M. K.
- Venue
- Nature
- Published
- 2021-11-10
- Volume
- 601
- Issue
- 7891
- Pages
- 110-117
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3212752300
- Cited by
- 405
- References
- 72
- FWCI
- 23.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. https://app.cochat.ai/papers/10.1038/s41586-021-04186-8
- The paper
- Swadling, L., Diniz, M. O., Schmidt, N. M., Amin, O. E., Chandran, A., Shaw, E., Pade, C., Gibbons, J. M., Le Bert, N., Tan, A. T., Jeffery-Smith, A., Tan, C. C. S., Tham, C. Y. L., Kucykowicz, S., Aidoo-Micah, G., Rosenheim, J., Davies, J., Johnson, M., Jensen, M. P., . . . Maini, M. K. (2022). Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature. https://doi.org/10.1038/s41586-021-04186-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.